Zhou, A., Knoche, E. M., Engle, E. K., Fisher, D. A. C., & Oh, S. T. (2015). Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib. Blood Cancer J.
Styl ChicagoZhou, A., E M. Knoche, E K. Engle, D A C. Fisher, a S T. Oh. "Concomitant JAK2 V617F-positive Polycythemia Vera and BCR-ABL-positive Chronic Myelogenous Leukemia Treated With Ruxolitinib and Dasatinib." Blood Cancer J 2015.
Citace podle MLAZhou, A., et al. "Concomitant JAK2 V617F-positive Polycythemia Vera and BCR-ABL-positive Chronic Myelogenous Leukemia Treated With Ruxolitinib and Dasatinib." Blood Cancer J 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..